Skip to main content
Equibles

Cornerstone Planning Group LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1822587 FAIRFIELD, NJ
Back to CRNX Full portfolio

Position in CRNX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$1,571
+$46 QoQ
Shares Held
42
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#236
of 267 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cornerstone Planning Group LLC holds $333,862 across 45 Biotechnology names. CRNX ranks #23 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 130 $64,574
2 RVMD
Revolution Medicines, Inc.
 199 $37,268
3 HALO
Halozyme Therapeutics, Inc.
 389 $30,447
4 ALNY
Alnylam Pharmaceuticals, Inc.
 97 $29,199
5 RPRX
Royalty Pharma plc
 373 $20,914
6 CRSP
CRISPR Therapeutics AG
 300 $16,362
7 ARGX
Argenx SE
 17 $15,772
8 ABCL
AbCellera Biologics Inc.
 2,000 $15,700

All Filings in CRNX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,571 42
2026-03-31 $1,525 42
2025-12-31 $1,955 42
2025-09-30 $1,749 42
2025-06-30 $115 4
2025-03-31 $134 4
2024-12-31 $204 4
2024-09-30 $204 4
2024-06-30 $179 4
2024-03-31 $187 4
2023-12-31 $142 4
2023-09-30 $118 4